
|Videos|April 8, 2022
Dr. Palese discusses same-day discharge following transurethral BPH procedures
Author(s)Urology Times staff
“Patients need to understand that even if you tell them that you may be doing this as an ambulatory procedure, they may actually have to stay afterwards, depending on what you find in the operating room or what happens in the postoperative period,” says Michael A. Palese, MD.
Advertisement
In this video, Michael A. Palese, MD, discusses the key takeaways of the recent Urology study, “The utilization and safety of same-day discharge after transurethral benign prostatic hyperplasia surgery: a case-control, matched analysis of a national cohort,” for which he served as senior author. Palese is the chairman of the department of urology and a professor of urology at the Icahn School of Medicine, Mount Sinai, New York, New York.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
2
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










